Proton pump inhibitor to protect the esophagus during lung radiation
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether taking a proton pump inhibitor (a common heartburn drug) before and during radiation therapy for lung cancer can protect the esophagus from damage. It may help people who are about to start radiation for any stage of lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have lung cancer (any type or stage, including non-small cell or small cell lung cancer)
- You are scheduled to receive at least 40 Gy of radiation in 15 treatments (or a similar dose)
- At least 5 cc of your esophagus will receive a high radiation dose
- You have not taken a proton pump inhibitor (like omeprazole, pantoprazole) in the last 3 months
- You do not have painful swallowing before starting the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two medicines, pentoxifylline and vitamin E, can help prevent a type of lung inflammation called pneumonitis in people with stage III non-small cell lung cancer who are getting chemoradiation and a checkpoint inhibitor. These medicines are already used for other conditions and may lower the risk of this side effect.
This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
This trial tests if giving radiation to the main lung tumor before starting a targeted therapy pill can help delay the cancer from growing. It is for people with advanced non-small cell lung cancer that has a specific genetic change and who have not had targeted therapy before.
This trial tests a new type of proton radiation for early-stage non-small cell lung cancer. It aims to see if it's safe and works well, with less damage to healthy tissue.
This trial studies whether adding propranolol (a common blood-pressure/heart medication) to standard chemotherapy and radiation can improve outcomes for people with esophageal adenocarcinoma. You would start propranolol around the time of treatment, with careful heart monitoring and study follow-up.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.